Nanotechnology: Recent Advances, Opportunities and Challenges

Year : 2024 | Volume : 26 | Issue : 03 | Page : 44 64
    By

    Shubham Gautam,

  • Moumita Barman,

  • Monika Singh,

  • Neha Tyagi,

  1. Research Scholar, I.T.S College of Pharmacy, Ghaziabad, Uttar pradesh, India
  2. Research Scholar, I.T.S. College of Pharmacy, Ghaziabad, Uttar pradesh, India
  3. Assistant Professor, I.T.S. College of Pharmacy, Ghaziabad, Uttar pradesh, India
  4. Research Scholar, RKGIT College OF Pharmacy, Ghaziabad, Uttar pradesh, India

Abstract

Nanotechnology, the science of the minuscule, has catalysed a revolution across diverse fields, from pharmacy to veterinary science. This abstract encapsulates the dynamic interplay between nanotechnology and healthcare, unveiling its transformative impact on drug delivery, cosmeceuticals, veterinary medicine, dentistry, and biotechnology. In pharmacy, nanotechnology pioneers targeted drug delivery systems, amplifying therapeutic efficacy while mitigating adverse effects. Nano-cosmeceuticals redefine beauty standards, infusing skincare, haircare, lip care, and nail care products with unparalleled penetration and stability. Veterinary science embraces nanotechnology’s potential, enhancing diagnosis, treatment delivery, and disease control in animals. Concurrently, dentistry explores nanomaterials’ potential, revolutionizing oral health treatments with improved qualities and novel applications. At the nexus of biology and nanotechnology, nanobiotechnology unveils a new frontier, offering transformative tools for studying biological phenomena and designing innovative therapies. This abstract serves as a portal into the dynamic landscape of nanotechnology in healthcare, where innovation converges with the infinitesimal to redefine the boundaries of possibility.

 

Keywords: Nanotechnology, targeted drug delivery, adverse effects, solid lipid nanoparticles, drug loading capacity

[This article belongs to Nano Trends – A Journal of Nano Technology & Its Applications ]

How to cite this article:
Shubham Gautam, Moumita Barman, Monika Singh, Neha Tyagi. Nanotechnology: Recent Advances, Opportunities and Challenges. Nano Trends – A Journal of Nano Technology & Its Applications. 2024; 26(03):44-64.
How to cite this URL:
Shubham Gautam, Moumita Barman, Monika Singh, Neha Tyagi. Nanotechnology: Recent Advances, Opportunities and Challenges. Nano Trends – A Journal of Nano Technology & Its Applications. 2024; 26(03):44-64. Available from: https://journals.stmjournals.com/nts/article=2024/view=179164


References

1. Pison U, Welte T, Giersing M, Groneberg DA. Nanomedicine for respiratory diseases. Eur J Pharmacol. 2006;533:341–350.
2. Brannon-Peppase L, Blanchette JQ. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56(11):1649–1659.
3. Stylios GK, Giannoudis PV, Wan T. Applications of nanotechnologies in medical practice. Injury. 2005;36:S6–S13.
4. Yokoyama M. Drug targeting with nano-sized carrier systems. J Artif Organs. 2005;8(2):77–84.
5. Schatzlein AG. Delivering cancer stem cell therapies – a role for nanomedicines? Eur J Cancer. 2006;42(9):1309–1315.
6. Ajazuddin SS. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010;81:176.
7. Mainardes RM, Urban M, Cinto POC, Chaud MV, Evangelista RCG, Gremião MPD. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv. 2006;3:275–285.
8. Grill AE, Johnston NW, Sadhukha T, Panyam J. A review of select recent patents on novel nanocarriers. Recent Pat Drug Deliv Formul. 2009;3:137–142.
9. Venugopal J, Prabhakaran MP, Low S. Continuous nanostructures for the controlled release of drugs. Curr Pharm Des. 2009;15:1799–1808.
10. Chorilli M, Brizante AC, Rodrigues CA, Salgado HRN. Aspectos gerais em sistemas transdérmicos de liberação de fármacos [General features of transdermal drug delivery]. Infarma. 2007;8:17–13. (Portuguese)
11. Nilesh J, Ruchi J, Navneet T, Brham Prakash G, Deepak Kumar J. Nanotechnology: A safe and effective drug delivery system. Asian J Pharmaceut Clin Res. 2010;3(3):159–165.
12. Rakesh P.P. Nanoparticles and its applications in the field of pharmacy. Available at: http://www.pharmainfo.net/reviews/nanoparticles-and-its-applications-field-phamacy. 2008.
13. Mroz P, Hashmi JT, Huang YY, Lange N, Hamblin MR. Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol. 2011;7:75–91.
14. Lim ME, Lee YL, Zhang Y, Chu JJH. Photodynamic inactivation of viruses using upconversion nanoparticles. Biomaterials. 2012;33:1912–1920.
15. Kharkwal GB, Sharma SK, Huang YY, Dai T, Hamblin MR. Photodynamic therapy for infections: Clinical applications. Lasers Surg Med. 2011;43:755–767.
16. Ribeiro MS, da Silva DdFT, Cristina Nunez S, Zezell MD. Laser em baixa intensidade. In: Técnicas e Procedimentos Terapêuticos. São Paulo, SP: Quintessense Editora; 2004. p. 945–953.
17. Dolmans DEJGJ, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–387.
18. Machado AEdH. Terapia fotodinâmica: Princípios, potencial de aplicação e perspectivas. Quim Nova. 2000;23:237–243.
19. Macdonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyr Phthalocyanines. 2001;5:105–129.
20. Allison RR, Moghissi K. Photodynamic therapy (PDT): PDT mechanisms. Clin Endosc. 2013;46:24–29.
21. Shah PM, Gerdes H. Endoscopic options for early-stage esophageal cancer. J Gastrointest Oncol. 2014;6:20–30.
22. Nanashima A, Nagayasu T. Current status of photodynamic therapy in digestive tract carcinoma in Japan. Int J Mol Sci. 2015;16:3434–3440.
23. Yano T, Muto M, Yoshimura K, Niimi M, Ezoe Y, Yoda Y, et al. Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer. Radiat Oncol. 2012;7.
24. Yano T, Muto M, Minashi K, Iwasaki J, Kojima T, Fuse N, et al. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: A phase II study. Int J Cancer. 2012;131:1228–1234.
25. Green B, Cobb ARM, Hopper C. Photodynamic therapy in the management of lesions of the head and neck. Br J Oral Maxillofac Surg. 2013;51:283–287.
26. Simone CB II, Cengel KA. Photodynamic therapy for lung cancer and malignant pleural mesothelioma. Semin Oncol. 2014;41:820–830.
27. Allison RR, Moghissi K. Oncologic photodynamic therapy: Clinical strategies that modulate mechanisms of action. Photodiagn Photodyn Ther. 2013;10:331–341.
28. Yoon I, Li JZ, Shim YK. Advances in photosensitizers and light delivery for photodynamic therapy. Clin Endosc. 2013;46:7–23.
29. Szaciłowski K, Macyk W, Drzewiecka-Matuszek A, Brindell M, Stochel G. Bioinorganic photochemistry: Frontiers and mechanisms. Chem Rev. 2005;105:2647–2694.
30. Baran TM, Foster TH. Comparison of flat cleaved and cylindrical diffusing fibers as treatment sources for interstitial photodynamic therapy. Med Phys. 2014;41.
31. Jockusch S, Lee D, Turro NJ, Leonard EF. Photo-induced inactivation of viruses: Adsorption of methylene blue, thionine, and thiopyronine on Qbeta bacteriophage. Proc Natl Acad Sci USA. 1996;93:7446–7451.
32. Phoenix DA, Harris F. Phenothiazinium-based photosensitizers: Antibacterials of the future? Trends Mol Med. 2003;9:283–285.
33. Harris F, Chatfield LK, Phoenix DA. Phenothiazinium-based photosensitizers—Photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr Drug Targets. 2005;6:615–627.
34. Tuite EM, Kelly JM. New trends in photobiology. J Photochem Photobiol B. 1993;21:103–124.
35. Millson CE, Wilson M, Macrobert AJ, Bedwell J, Bown SG. The killing of Helicobacter pylori by low-power laser light in the presence of a photosensitizer. J Med Microbiol. 1996;44:245–252.
36. Tardivo JP, del Giglio A, de Oliveira CS, Gabrielli DS, Junqueira HC, Tada DB, et al. Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagn Photodyn Ther. 2005;2:175–191.
37. Wagner M, Suarez ER, Theodoro TR, Machado Filho CDAS, Gama MF, Tardivo JP, et al. Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases. Clin Exp Dermatol. 2012;37:527–533.
38. Kessel D, Thompson P. Purification and analysis of hematoporphyrin and hematoporphyrin derivative by gel exclusion and reverse-phase chromatography. Photochem Photobiol. 1987;46:1023–1025.
39. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian solid gold. In: Aggarwal BB, Surh YJ, Shishodia S, editors. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Boston, MA: Springer; 2007. p. 1–75.
40. Lee WH, Loo CY, Bebawy M, Luk F, Mason RS, Rohanizadeh R. Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol. 2013;11:338–378.
41. Haukvik T, Bruzell E, Kristensen S, Tønnesen HH. Photokilling of bacteria by curcumin in selected polyethylene glycol 400 (PEG 400) preparations. Pharmazie. 2010;65:600–606.
42. LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, et al. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res. 2005;11:6994–7002.
43. Allen CM, Sharman WM, van Lier JE. Current status of phthalocyanines in the photodynamic therapy of cancer. J Porphyr Phthalocyanines. 2001;5:161–169.
44. Ranyuk E, Cauchon N, Klarskov K, Guérin B, van Lier JE. Phthalocyanine-peptide conjugates: Receptor-targeting bifunctional agents for imaging and photodynamic therapy. J Med Chem. 2013;56(4):1520–1534.
45. Zasedatelev AV, Dubinina TV, Krichevsky DM, Krasovskii VI, Gak VY, Pushkarev VE, et al. Plasmon-induced light absorption of phthalocyanine layer in hybrid nanoparticles: Enhancement factor and effective spectra. J Phys Chem C. 2016;120(3):1816–1823.
46. Kleemann B, Loos B, Scriba TJ, Lang D, Davids LM. St John’s wort (Hypericum perforatum L.) photomedicine: Hypericin-photodynamic therapy induces metastatic melanoma cell death. PLoS ONE. 2014;9(6):e103762.
47. Maduray K, Davids L. The anticancer activity of hypericin in photodynamic therapy. J Bioanal Biomed. 2012;2012.
48. Kubin A, Wierrani F, Burner U, Alth G, Grunberger W. Hypericin—The facts about a controversial agent. Curr Pharm Des. 2005;11(2):233–253.
49. Muehlmann LA, Ma BC, Longo JPF, Almeida Santos MF, Azevedo RB. Aluminum-phthalocyanine chloride associated to poly (methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy. Int J Nanomed. 2014;9:1199–1213.
50. Konan YN, Gurny R, Allémann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B. 2002;66(2):89–106.
51. Roozeboom MH, Aardoom MA, Nelemans PJ, Thissen MRTM, Kelleners-Smeets NWJ, Kuijpers DIM, et al. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: A randomized controlled trial with at least 5-year follow-up. J Am Acad Dermatol. 2013;69(2):280–287.
52. Mukta S, Adam F. Cosmeceuticals in day-to-day clinical practice. J Drugs Dermatol. 2010;9(1):62–69.
53. ResearchGate. Photosensitizers currently in various stages of clinical trials for photo-based therapy. [Online]. Available from: https://www.researchgate.net/figure/Photosensitizers-currently-in-various-stages-of-clinical-trials-for-photo-based_tbl3_235885483
54. Semanticscholar. Enhanced Intracellular Photosensitizer Uptake and Cytotoxicity by Nanoparticles. [Online]. Available from: https://www.semanticscholar.org/paper/Enhanced-Intracellular-Photosensitizer-Uptake-and-Chizenga-Abrahamse/845b0f4773f516d29b00ba858da1ac523acadb32/figure/3
55. Srinivas K. The current role of nanomaterials in cosmetics. J Chem Pharm Res. 2016;8(5):906–914.
56. Brandt FS, Cazzaniga A, Hann M. Cosmeceuticals: Current trends and market analysis. Semin Cutan Med Surg. 2011;30(3):141–143.
57. Mu L, Sprando RL. Application of nanotechnology in cosmetics. Pharm Res. 2010;27(8):1746–1749.
58. Nohynek GJ, Lademann J, Ribaud C, Roberts MS. Grey Goo on the skin? Nanotechnology, cosmetic, and sunscreen safety. Crit Rev Toxicol. 2007;37(3):251–277.
59. ResearchGate. Schematic representation of different types of nanocarriers used in drug delivery. [Online]. Available from: https://www.researchgate.net/profile/Monica-Alves/publication/331437049/figure/fig3/AS:1151992986648588@1651667939603/Schematic-representation-of-different-types-of-nanocarriers-used-in-drug-delivery.png
60. ResearchGate. Major classes in nanocosmeceuticals. [Online]. Available from: https://www.researchgate.net/publication/324064740/figure/fig12/AS:1086433397866496@1636037315132/Major-classes-in-nanocosmeceuticals.jpg
61. Lohani A, Verma A, Joshi H, Yadav N, Karki N. Nanotechnology-based cosmeceuticals. ISRN Dermatol. 2014;2014:843687.
62. Smijs TG, Pavel S. Titanium dioxide and zinc oxide nanoparticles in sunscreens: Focus on their safety and effectiveness. Nanotechnol Sci Appl. 2011;4:95–112.
63. Glaser DA. Anti-aging products and cosmeceuticals. Facial Plast Surg Clin North Am. 2004;12(3):363–372.
64. Rosen J, Landriscina A, Friedman A. Nanotechnology-based cosmetics for hair care. Cosmetics. 2015;2(4):211–224.
65. Hu Z, Liao M, Chen Y, et al. A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone. Int J Nanomed. 2012;7:5719–5724.
66. Tripura P, Anushree H. Novel delivery systems: Current trend in cosmetic industry. Eur J Pharm Med Res. 2017;4(8):617–627.
67. Dermacare Direct. Sesderma Fillderma Lip. [Online]. Available from: https://www.dermacare-direct.co.uk/sesderma-fillderma-lip.html
68. Bethany H. Zapping nanoparticles into nail polish. Laser ablation method makes cosmetic and biomedical coatings in a flash. 2017;95(12):9.
69. Pereira L, Dias N, Carvalho J, Fernandes S, Santos C, Lima N. Synthesis, characterization, and antifungal activity of chemically and fungal-produced silver nanoparticles against Trichophyton rubrum. J Appl Microbiol. 2014;117(6):1601–1613.
70. ResearchGate. Various marketed formulations of liposomes. [Online]. Available from: https://www.researchgate.net/figure/Various-Marketed-Formulations-of-Liposomes_tbl1_282693545
71. Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. Nanoparticles as drug delivery systems. Pharmacol Rep. 2012;64(5):1020–1037.
72. Scott NR. Nanoscience in veterinary medicine. Vet Res Commun. 2007;31(2):139–144.
73. Assadi P. A novel multiplication algorithm in nanotechnology. J Appl Sci. 2008;8(5):2625–2630.
74. Sahoo S, Ma W, Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel loaded nanoparticles in a murine model of prostate cancer. Int J Cancer. 2004;112(2):335–340.
75. Sekhon B, Saluja V, Sekhon BS. Nanovaccines—An overview. Int J Pharm Frontier Res. 2011;1(1):101–109.
76. Gheibi Hayat SM, Darroudi M. Nanovaccine: A novel approach in immunization. J Cell Physiol. 2019;234(11):12530–12536.
77. Nordly P, Madsen H, Nielsen H, Foged C. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Expert Opin Drug Deliv. 2009;6(6):657–672.
78. Yang LAP. Physiochemical aspects of drug delivery and release from polymer-based colloids. Curr Opin Colloid Interface Sci. 2000;5(2):132–143.
79. Underwood C, Van E. Nanomedicine and veterinary science: The reality and the practicality. Vet J. 2012;193(1):12–23.
80. Verma O, Kumar R, Kumar A, Chand S. Assisted reproductive techniques in farm animal: From artificial insemination to nanobiotechnology. Vet World. 2012;5(5):301–310.
81. Monerris M, Arévalo F, Fernández H, Zon M, Molina P. Integrated electrochemical immunosensor with gold nanoparticles for the determination of progesterone. Sens Actuators B Chem. 2012;166:586–592.
82. Wang T, Zhao G, Liang X, Xu Y, Li Y, et al. Numerical simulation of the effect of superparamagnetic nanoparticles on microwave rewarming of cryopreserved tissues. Cryobiology. 2014;68(3):234–243.
83. Weibel M, Badano J, Rintoul I. Technological evolution of hormone delivery systems for estrous synchronization in cattle. Int J Livest Res. 2014;4(1):20–40.
84. O’Connell MJ, Bachilo SM, Huffman CB, Moore VC, Strano MS. Band gap fluorescence from individual single-walled carbon nanotubes. Sci. 2002;297(5581):593–596.
85. Vet World. Nanotechnology in veterinary and animal science. 2012;2(11):475–477.
86. Eijkel TCJ, Berg DVA. Nanofluidics: What is it and what can we expect from it? Microfluid Nanofluid. 2005;1(4):249–267.
87. Suh R, Phadke N, Ohl D, Takayama S, Smith G. In vitro fertilization within microchannels requires lower total numbers and lower concentrations of spermatozoa. Hum Reprod. 2006;21(2):477–483.
88. Schuster T, Cho B, Keller L, Takayama S, Smith G. Isolation of motile sperm from semen samples using microfluidics. Reprod Biomed. 2003;7(1):75–81.
89. Jain KK. Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta. 2005;358(1–2):37–54.
90. Bentolila L, Ebenstein Y, Weiss S. Quantum dots for in vivo small-animal imaging. J Nucl Med. 2009;50(3):493–496.
91. Shreya G, Christopher G, Feng C, Weibo C. Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics. Adv Drug Deliv Rev. 2016;3:20.
92. Cai W, Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small. 2007;3(11):1840–1854.
93. Lucignani G, Bombardieri E. Molecular imaging: Seeing the invisible beyond the “hot spot”. Q J Nucl Med Mol Imaging. 2004;48(1):1–3.
94. Galldiks N, Stoffels G, Ruge M, Rapp M, Sabel M, et al. Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma. J Nucl Med. 2013;54:2046–2054.
95. LeBlanc AK, Jakoby BW, Townsend DW, Daniel GB. 18FDG-PET imaging in canine lymphoma and cutaneous mast cell tumor. Vet Radiol Ultrasound. 2009;50:215–223.
96. Malik S, Muhammad K, Wahed Y. Emerging Applications of Nanotechnology in Healthcare and Medicine. Mol. 2023;28(18):6624.
97. Schmalz G, Hickel R, Van Landuyt KL, Reichl FX. Scientific update on nanoparticles in dentistry. Int Dent J. 2018;68:299–305.
98. Bhardwaj A, Bhardwaj A, Misuriya A, Maroli S, Manjula S, Singh AK. Nanotechnology in dentistry: Present and future. J Int Oral Health. 2014;6:121–126.
99. Mantri SS, Mantri S. The nano era in dentistry. J Nat Sci Biol Med. 2013;4:39–44.
100. Roberson J, O.H. Harald, Sturdevant E.J. Sturdevant’s Art and Science of Operative Dentistry. USA: Elsevier; 2006. 807–840.
101. Freitas RA. Nanodentistry. J Am Dent Assoc. 2000;131:1559–1565.
102. Kavoosi F, Modaresi F, Sanaei M, Rezaei Z. Medical and dental applications of nanomedicines. APMIS. 2018;126:795–803.
103. Bayne SC. Dental biomaterials: Where are we and where are we going? J Dent Educ. 2005;69:571–585.
104. Maxfield BJ, Hamdan AM, Tüfekçi E, Shroff B, Best AM, Lindauer SJ. Development of white spot lesions during orthodontic treatment: Perceptions of patients, parents, orthodontists, and general dentists. Am J Orthod Dentofac Orthop. 2012;141:337–344.
105. Gentle Dental. What are orthodontic elastics (rubber bands)? [Online]. Available from: https://www.interdent.com/gentle-dental/resources/what-are-orthodontic-elastics-rubber-bands/
106. Prabha RD, Kandasamy R, Sivaraman US, Nandkumar MA, Nair PD. Antibacterial nanosilver coated orthodontic bands with potential implications in dentistry. Indian J Med Res. 2016;144:580–586.
107. Moreira DM, Oei J, Rawls HR, Wagner J, Chu L, Li Y, et al. A novel antimicrobial orthodontic band cement with in situ–generated silver nanoparticles. Angle Orthod. 2015;85:175–183.
108. Costa A, Raffainl M, Melsen B. Miniscrews as orthodontic anchorage: A preliminary report. Int J Adult Orthod Orthognath Surg. 1998;13:201–209.
109. Reynders R, Ronchi L, Bipat S. Mini-implants in orthodontics: A systematic review of the literature. Am J Orthod Dentofac Orthop. 2009;135:564.e1–564.e19.
110. Tsui W, Chua H, Cheung LK. Bone anchor systems for orthodontic application: A systematic review. Int J Oral Maxillofac Surg. 2012;41:1427–1438.
111. Leung MTC, Lee TCK, Rabie ABM, Wong RWK. Use of Miniscrews and Miniplates in Orthodontics. J Oral Maxillofac Surg. 2008;66:1461–1466.
112. Rapoport LP, Bilik Y, Feldman YA, Homyonfer M, Cohen SR, Tenne R. Hollow nanoparticles of WS2 as potential solid-state lubricants. Nat Cell Biol. 1997;387:791–793.
113. Sawhney R, Sharma R, Sharma K. Microbial colonization on elastomeric ligatures during orthodontic therapeutics: An overview. Turk J Orthod. 2018;31:21–25.
114. Seres L, Kocsis A. Closure of severe skeletal anterior open bite with zygomatic anchorage. J Craniofacial Surg. 2009;20:478–482.
115. Sharan J, Singh S, Lale S, Mishra M, Koul V, Kharbanda OP. Applications of nanomaterials in dental science: A review. J Nanosci Nanotechnol. 2017;17:2235–2255.
116. JNJ Ortho. Orthodontic mini-screw demonstration model. [Online]. Available from: https://www.jnjortho.com/product-page/orthodontic-mini-screw-demonstration-model
117. Rossi M, Bruno G, De Stefani A, Perri A, Gracco A. Quantitative CBCT evaluation of maxillary and mandibular cortical bone thickness and density variability for orthodontic miniplate placement. Int Orthod. 2017;15:610–624.
118. Gracco A, Lombardo L, Cozzani M, Siciliani G. Quantitative cone-beam computed tomography evaluation of palatal bone thickness for orthodontic miniscrew placement. Am J Orthod Dentofac Orthop. 2008;134:361–369..
119. Gracco A, Lombardo L, Cozzani M, Siciliani G. Quantitative evaluation with CBCT of palatal bone thickness in growing patients. Prog Orthod. 2006;7:164–174.
120. Jang I, Choi DS, Lee JK, Kim WT, Cha BK, Choi WY. Effect of drug-loaded TiO2 nanotube arrays on osseointegration in an orthodontic miniscrew: An in-vivo pilot study. Biomed Microdevices. 2017;19:94.
121. Jang I, Shim SC, Choi DS, Cha BK, Lee JK, Choe BH, et al. Effect of TiO2 nanotubes arrays on osseointegration of orthodontic miniscrew. Biomed Microdevices. 2015;17:76.
122. Bawa R, Audette GF, Rubinstein I. Handbook of Clinical Nanomedicine: Nanoparticles, Imaging, Therapy, and Clinical Applications. Singapore: Pan Stanford; 2016.
123. Hulla JE, Sahu SC, Hayes AW. Nanotechnology: History and future. Hum Exp Toxicol. 2015;34(12):1318–1321.
124. Jain KK. Applications of biochips: From diagnostics to personalized medicine. Curr Opin Drug Discov Dev. 2004;7(3):285–289.
125. Brown EMB. Nanomedicine advancements in cancer diagnosis and treatment. Horizons Clin Nanomedi. 2014;67.
126. Freitas RA. Nanotechnology, nanomedicine and nanosurgery. Int J Surg. 2005;4(3):243–246.
127. Ebbesen M, Jensen TG. Nanomedicine: Techniques, potentials, and ethical implications. Biomed Res Int. 2006.
128. Fankhauser F, Niederer PF, Kwasniewska S, van der Zypen E. Supernormal vision, high-resolution retinal imaging, multiphoton imaging and nanosurgery of the cornea–a review. Technol Health Care. 2004;12(6):443–453.
129. Lamounier JA, Moulin ZS, Xavier CC. Recommendations for breastfeeding during maternal infections. J Pediatr. 2004;80(5):s181–s188.

Regular Issue Subscription Review Article
Volume 26
Issue 03
Received 23/09/2024
Accepted 05/10/2024
Published 22/10/2024
Publication Time 29 Days
660

Login


My IP

PlumX Metrics